Eleanor Blalock is a member of the Health Analytics practice. She currently concentrates on healthcare-related strategy and litigation consulting with a focus on data analysis.
She specializes in leveraging large datasets to gain insight into the opportunities and risks facing healthcare entities. She works with clients across the healthcare industry, including pharmaceutical manufacturers, industry groups, hospitals, pharmacy benefit managers, and insurers.
Ms. Blalock has significant experience assisting clients with aspects of the 340B drug discount program. She has published extensively on issues related to 340B and on pharmaceutical pricing issues generally.
International Development Systems
2012 – 2013
Cleary Gottlieb Steen & Hamilton LLP
2011 – 2012
2009 – 2011
Areas of Expertise
BSFS, International Economics and Latin American Studies, 2009